CINCINNATI, April 27 /PRNewswire-FirstCall/ -- LCA-Vision
Inc. (Nasdaq: LCAV), a leading provider of laser vision correction
services under the LasikPlus® brand, today announced
financial and operating results for the three months ended
March 31, 2010.
First Quarter 2010 Operational and Financial Results (all
comparisons are with the first quarter of 2009)
- Revenues were $34.0 million
compared with $47.9 million; adjusted
revenues were $32.3 million compared
with $44.9 million.
- Procedure volume was 19,066 procedures (62 vision centers)
compared with 27,859 reported procedures (75 vision centers) and
25,491 same-store procedures.
- Same-store revenues (62 vision centers) decreased 23.1%;
adjusted same-store revenues decreased 21.6%.
- Operating loss was $0.7 million
compared with operating loss of $4.2
million; adjusted operating loss was $2.2 million compared with adjusted operating
loss of $6.9 million. Operating
loss and adjusted operating loss for the first quarter of 2010
reflected a $1.3 million gain on the
sale of equipment and a $0.3 million
restructuring expense. Operating loss and adjusted operating loss
for the first quarter of 2009 included a $0.9 million restructuring expense and
$0.8 million in consent revocation
expenses.
- Net loss was $0.6 million, or
$0.03 per share, compared with net
loss of $2.8 million, or $0.15 per share.
- Cash and investments totaled $56.3
million as of March 31, 2010,
compared with $54.6 million as of
December 31, 2009.
Since the first quarter of 2007, LCA-Vision has provided both
adjusted revenues and operating losses as a means of measuring
performance that adjusts for the non-cash impact of accounting for
separately priced extended warranties. A reconciliation of
revenues and operating losses as reported in accordance with U.S.
Generally Accepted Accounting Principles (GAAP) is provided at the
end of this news release. Management believes the adjusted
information better reflects operating performance and, therefore,
is more meaningful to investors.
"Our procedure volume and operating results continue to be
adversely affected by the general economic slowdown and associated
decline in consumer confidence levels and high-end discretionary
expenditures for many consumers," said LCA-Vision Chief Financial
Officer Michael J. Celebrezze.
"Despite the difficult environment, we are reporting positive
operating cash flow, and a reduction in year-over-year operating
loss, due mainly to previously announced measures to conserve cash
and reduce expenses to better align our operations with current
market demand. Our cash and investment balances increased by
$1.7 million since December 31, 2009, totaling $56 million as of March
31, 2010. As a result of our previously announced tax
refund expected in June, we expect positive cash flow for the
second quarter.
"Procedure volume was positively impacted by seasonality;
however, severe inclement weather, particularly on the East Coast,
had a negative effect on our business in the first quarter.
Our managed care business remained strong, but the growing
contribution from managed care negatively affected price per
procedure," he added.
Chief Operating Officer David L.
Thomas commented, "We are encouraged by year-over-year and
sequential-quarter increases in our appointment show rate and
treatment show rate, and sequential-quarter improvement in our
conversion rate. We attribute these improvements in
conversion metrics primarily to patient acquisition and operations
efficiency measures. Marketing spend per procedure was
reduced to $413, from $468 a year ago and $493 in the 2009 fourth quarter. We held
quarterly marketing expenses to $7.9
million as we attempted to match spending with perceived
consumer demand. We are continuing to revamp our marketing
programs to drive procedure volume. To encourage increased
traffic, we are offering a network-wide 15% discount on procedures
during the second quarter, while our marketing plans are being
finalized."
Near-term Financial Outlook
LCA-Vision intends to continue to manage cash flow
conservatively in 2010. The company affirmed its plans and
outlook for the year, as follows:
- The company does not plan to open any new vision centers in the
near term. LCA-Vision will consider restarting its de
novo new center opening program when market conditions
improve.
- The company will continue to manage general and administrative
expenses aggressively, which it expects will decline slightly in
2010 from 2009 levels.
- The company expects direct costs per center to decline slightly
in 2010 from 2009.
- The company expects marketing and advertising spend for the
2010 second quarter to range from $6.5
million to $7.5 million.
- The company expects capital expenditures of $1.2 million in 2010 for vision center
renovations and equipment replacement.
- The company expects to receive a federal tax refund of
$10 million to $11 million in the
2010 second quarter.
- The company anticipates an effective tax rate of approximately
1% for 2010 due to a full valuation allowance on net deferred tax
assets.
As a result of aggressive efforts to reduce costs, the number of
procedures per vision center required to reach breakeven has
declined to 95 per month. LCA-Vision estimates the number of
procedures companywide required for breakeven cash flow, excluding
any tax refunds and after capital expenditures and debt service, to
be approximately 95,000 per year. The company believes that
it has sufficient cash and investments to fund its business beyond
2012 if it performs at least 65,000 procedures annually.
Conference Call and Webcast
As previously announced, a conference call and webcast will be
held today beginning at 10:00 a.m. Eastern
time. To access the conference call, dial 866-322-1352
(United States and Canada) or 706-643-6246 (international
callers). The webcast will be available at the investor
relations section of LCA-Vision's website. A replay of the
call and webcast will begin approximately two hours after the live
call has ended. To access the replay, dial 800-642-1687
(United States and Canada) or 706-645-9291 (international
callers) and enter the conference ID number: 628 511 18.
Forward-Looking Statements
This news release contains forward-looking statements based on
current expectations, forecasts and assumptions of LCA-Vision that
are subject to risks and uncertainties. The forward-looking
statements in this release are based on information available to us
as of the date hereof. Actual results could differ materially
from those stated or implied in our forward-looking statements due
to risks and uncertainties associated with our business. In
addition to the risk factors discussed in our Form 10-K and other
filings with the Securities and Exchange Commission, there are a
number of other risks and uncertainties associated with our
business, including, without limitation, the successful execution
of marketing strategies cost effectively to drive patients to our
vision centers; the impact of low consumer confidence and
discretionary spending; competition in the laser vision correction
industry; our ability to attract new patients; the possibility of
adverse outcomes or long-term side effects of laser vision
correction and negative publicity regarding laser vision
correction; our ability to operate profitable vision centers and
retain qualified personnel during periods of lower procedure
volumes; the continued availability of non-recourse third-party
financing for our patients on terms similar to what we have paid
historically; and the future value of revenues financed by us and
our ability to collect on such financings, which will in turn
depend on a number of factors, including the worsening consumer
credit environment and our ability to manage credit risk related to
consumer debt, bankruptcies and other credit trends.
Further, the FDA's advisory board on ophthalmic devices is
currently reviewing concerns about post-LASIK quality of life
matters, and the FDA has planned a major new study on LASIK
outcomes and quality of life that is expected to end in 2012.
The FDA or another agency could take legal or regulatory
action against us or others in the laser vision correction
industry. The outcome of this review or legal or regulatory
action could potentially impact negatively the acceptance of LASIK.
In addition, the acceptance rate of new technologies and our
ability to implement successfully new technologies on a national
basis create additional risk. Except to the extent required
under the federal securities laws and the rules and regulations
promulgated by the Securities and Exchange Commission, we assume no
obligation to update the information included in this news release,
whether as a result of new information, future events or
circumstances, or otherwise.
About LCA-Vision
Inc./LasikPlus®
LCA-Vision Inc., a leading provider of laser vision correction
services under the LasikPlus® brand, operates 62
LasikPlus® fixed-site laser vision correction
centers in 29 states and 45 markets in the United States. Additional company
information is available at www.lca-vision.com and
www.lasikplus.com.
Earning Trust Every Moment; Building Relationships for a
Lifetime.
For Additional Information
|
|
|
Company Contact:
|
Investor Relations Contact:
|
|
Barb Kise
|
Jody Cain
|
|
LCA-Vision Inc.
|
Lippert/Heilshorn & Associates
|
|
513-792-9292
|
310-691-7100
|
|
|
|
LCA-Vision
Inc.
|
|
Condensed
Consolidated Statements of Operations (Unaudited)
|
|
(Amounts in
thousands except per share data)
|
|
|
|
|
|
|
|
Three months ended
March 31,
|
|
|
2010
|
|
2009
|
|
|
|
|
|
|
Revenues - Laser refractive
surgery
|
$
34,013
|
|
$
47,921
|
|
|
|
|
|
|
Operating costs and
expenses
|
|
|
|
|
Medical
professional and license fees
|
8,337
|
|
10,776
|
|
Direct costs of
services
|
13,114
|
|
17,816
|
|
General and
administrative expenses
|
3,789
|
|
4,418
|
|
Marketing and
advertising
|
7,867
|
|
13,026
|
|
Depreciation
|
2,542
|
|
4,358
|
|
Consent revocation
solicitation charges
|
-
|
|
804
|
|
Restructuring
charges
|
338
|
|
916
|
|
Other,
net
|
-
|
|
(14)
|
|
|
35,987
|
|
52,100
|
|
Gain on sale of
assets
|
1,293
|
|
2
|
|
|
|
|
|
|
Operating loss
|
(681)
|
|
(4,177)
|
|
|
|
|
|
|
Equity in earnings from unconsolidated
businesses
|
25
|
|
27
|
|
Net investment income
(loss)
|
151
|
|
(177)
|
|
|
|
|
|
|
Loss before taxes on income
|
(505)
|
|
(4,327)
|
|
|
|
|
|
|
Income tax expense
(benefit)
|
59
|
|
(1,483)
|
|
|
|
|
|
|
Net loss
|
$
(564)
|
|
$
(2,844)
|
|
|
|
|
|
|
Loss per common share
|
|
|
|
|
Basic
|
$
(0.03)
|
|
$
(0.15)
|
|
Diluted
|
$
(0.03)
|
|
$
(0.15)
|
|
|
|
|
|
|
Weighted average shares
outstanding
|
|
|
|
|
Basic
|
18,633
|
|
18,561
|
|
Diluted
|
18,633
|
|
18,561
|
|
|
|
|
|
LCA-Vision
Inc.
|
|
Condensed
Consolidated Balance Sheets (Unaudited)
|
|
(Dollars in
thousands)
|
|
|
|
|
March 31,
2010
|
|
December 31,
2009
|
|
Assets
|
|
|
|
|
Current assets
|
|
|
|
|
Cash and cash
equivalents
|
$
17,778
|
|
$
24,049
|
|
Short-term
investments
|
36,488
|
|
28,455
|
|
Patient receivables, net of
allowance for doubtful accounts of $2,104 and $1,645
|
3,863
|
|
4,562
|
|
Other accounts
receivable
|
3,165
|
|
2,002
|
|
Assets held for sale
|
405
|
|
1,031
|
|
Prepaid professional
fees
|
571
|
|
615
|
|
Prepaid income taxes
|
12,090
|
|
12,270
|
|
Deferred compensation plan
assets
|
-
|
|
400
|
|
Prepaid expenses and
other
|
4,053
|
|
5,582
|
|
|
|
|
|
|
Total current assets
|
78,413
|
|
78,966
|
|
|
|
|
|
|
Property and equipment
|
79,860
|
|
79,993
|
|
Accumulated depreciation and
amortization
|
(56,381)
|
|
(53,995)
|
|
Property and equipment, net
|
23,479
|
|
25,998
|
|
|
|
|
|
|
Long-term investments
|
2,078
|
|
2,090
|
|
Patient receivables, net of allowance
for doubtful accounts of $586 and $1,674
|
681
|
|
854
|
|
Investment in unconsolidated
businesses
|
167
|
|
137
|
|
Other assets
|
4,466
|
|
4,590
|
|
|
|
|
|
|
Total assets
|
$
109,284
|
|
$
112,635
|
|
|
|
|
|
|
Liabilities and Stockholders'
Investment
|
|
|
|
|
Current liabilities
|
|
|
|
|
Accounts payable
|
$
8,537
|
|
$
6,504
|
|
Accrued liabilities and
other
|
11,800
|
|
11,581
|
|
Deferred revenue
|
5,707
|
|
6,151
|
|
Deferred compensation
liability
|
-
|
|
400
|
|
Debt obligations maturing in
one year
|
3,557
|
|
3,998
|
|
|
|
|
|
|
Total current liabilities
|
29,601
|
|
28,634
|
|
|
|
|
|
|
Long-term rent obligations and
other
|
2,247
|
|
2,395
|
|
Long-term debt obligations (less
current portion)
|
7,502
|
|
9,145
|
|
Insurance reserve
|
8,603
|
|
9,154
|
|
Deferred license fee
|
4,087
|
|
4,428
|
|
Deferred revenue
|
6,583
|
|
7,852
|
|
|
|
|
|
|
Stockholders' Investment
|
|
|
|
|
Common stock ($.001 par value;
25,291,637 and 25,287,387 shares and
|
|
|
|
|
18,663,421 and
18,619,185 shares issued and outstanding, respectively)
|
25
|
|
25
|
|
Contributed capital
|
174,515
|
|
174,325
|
|
Common stock in treasury, at
cost (6,628,216 shares and 6,668,202 shares)
|
(114,394)
|
|
(114,668)
|
|
Retained deficit
|
(10,760)
|
|
(9,729)
|
|
Accumulated other comprehensive
income
|
1,275
|
|
1,074
|
|
Total stockholders'
investment
|
50,661
|
|
51,027
|
|
|
|
|
|
|
Total liabilities and stockholders'
investment
|
$
109,284
|
|
$
112,635
|
|
|
|
|
|
|
|
|
|
|
LCA-Vision
Inc.
|
|
Condensed
Consolidated Statements of Cash Flows (Unaudited)
|
|
(Dollars in
thousands)
|
|
|
|
|
|
|
|
Three months ended
March 31,
|
|
|
2010
|
|
2009
|
|
|
|
|
|
|
Cash flow from operating
activities:
|
|
|
|
|
Net loss
|
$
(564)
|
|
$
(2,844)
|
|
Adjustments to reconcile net income to
net cash provided by operating activities:
|
|
|
|
|
Depreciation
|
2,542
|
|
4,358
|
|
Provision for loss on doubtful
accounts
|
828
|
|
1,175
|
|
Loss on investments
|
-
|
|
365
|
|
Impairment charges
|
-
|
|
872
|
|
Gain on sale of
assets
|
(1,293)
|
|
(2)
|
|
Deferred income
taxes
|
-
|
|
(136)
|
|
Stock-based
compensation
|
176
|
|
(8)
|
|
Insurance reserve
|
(551)
|
|
167
|
|
Equity in earnings of
unconsolidated affiliates
|
(25)
|
|
(27)
|
|
Changes in operating assets and
liabilities:
|
|
|
|
|
Patient accounts
receivable
|
44
|
|
286
|
|
Other accounts
receivable
|
(368)
|
|
(1,327)
|
|
Prepaid income
taxes
|
180
|
|
1,399
|
|
Prepaid expenses and
other
|
1,529
|
|
(72)
|
|
Accounts
payable
|
2,033
|
|
1,109
|
|
Deferred revenue, net of
professional fees
|
(1,542)
|
|
(2,753)
|
|
Accrued liabilities and
other
|
56
|
|
4,769
|
|
|
|
|
|
|
Net cash provided by
operations
|
3,045
|
|
7,331
|
|
|
|
|
|
|
Cash flow from investing
activities:
|
|
|
|
|
Purchases of property and
equipment
|
(20)
|
|
(157)
|
|
Proceeds from sale of assets
held for sale
|
1,124
|
|
-
|
|
Purchases of investment
securities
|
(81,771)
|
|
(81,478)
|
|
Proceeds from sale of
investment securities
|
73,752
|
|
81,841
|
|
Other, net
|
(65)
|
|
(206)
|
|
|
|
|
|
|
Net cash used in investing
activities
|
(6,980)
|
|
-
|
|
|
|
|
|
|
Cash flow from financing
activities:
|
|
|
|
|
Principal payments of capital
lease obligations and loan
|
(2,084)
|
|
(1,853)
|
|
Shares repurchased for treasury
stock
|
(192)
|
|
(36)
|
|
Exercise of stock
options
|
14
|
|
-
|
|
|
|
|
|
|
Net cash used in financing
activities
|
(2,262)
|
|
(1,889)
|
|
|
|
|
|
|
Net effect of exchange rate changes on
cash and cash equivalents
|
(74)
|
|
124
|
|
|
|
|
|
|
(Decrease) increase in cash and cash
equivalents
|
(6,271)
|
|
5,566
|
|
|
|
|
|
|
Cash and cash equivalents at beginning
of period
|
24,049
|
|
23,648
|
|
|
|
|
|
|
Cash and cash equivalents at end of
period
|
$
17,778
|
|
$
29,214
|
|
|
|
|
|
|
|
|
|
|
LCA-Vision Inc.
Effect of the Change in Accounting for Deferred Revenues on
Financial Results
(Dollars in thousands)
(Unaudited)
To supplement its Condensed Consolidated Financial Statements
presented in accordance with accounting principles generally
accepted in the United States,
LCA-Vision discusses adjusted revenues and operating income.
Management utilizes this information as a means of measuring
performance that adjusts for the non-cash impact of the accounting
for separately priced extended warranties and believes that
including this additional disclosure is meaningful to investors for
the same reason.
Accordingly, this news release contains non-GAAP financial
measures within the meaning of Regulation G promulgated by the
Securities and Exchange Commission. A reconciliation of the
difference between the non-GAAP measures with the most directly
comparable financial measures calculated in accordance with GAAP
follows:
|
|
Three Months Ended
March 31,
|
|
|
|
2010
|
|
2009
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
Reported U.S.
GAAP
|
|
$
34,013
|
|
$
47,921
|
|
Adjustments
|
|
|
|
|
|
Amortization of prior deferred revenue
|
|
(1,713)
|
|
(3,059)
|
|
Adjusted
revenues
|
|
$
32,300
|
|
$
44,862
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Loss
|
|
|
|
|
|
|
|
|
|
|
|
Reported U.S.
GAAP
|
|
$
(681)
|
|
$
(4,177)
|
|
Adjustments
|
|
|
|
|
|
Amortization of prior deferred revenue
|
|
(1,713)
|
|
(3,059)
|
|
Amortization of prior professional fees
|
|
171
|
|
306
|
|
Adjusted operating
loss
|
|
$
(2,223)
|
|
$
(6,930)
|
|
|
|
|
|
|
|
|
|
|
|
|
SOURCE LCA-Vision Inc.